In many organisms early embryogenesis is characterised by a period refractory to transcription. In Caenorhabditis elegans, the one-cell embryo is transcriptionally inactive, but at around eight-cell stage transcription is activated in the somatic lineage. This model suggests that histone tail modifications associated with activation of transcription, such as di-or trimethylation of histone 3 on lysine 4 (H3K4me2/me3) should be enriched in the somatic lineage. Here, we have investigated the deposition of H3K4me3 during embryogenesis and found that it is more dynamic than anticipated. In the eight-cell stage embryo, H3K4me3 deposition is poor in the germline blastomere, as expected, but surprisingly three somatic blastomeres also remain poor in H3K4me3. All the other somatic blastomeres show robust deposition of H3K4me3. Interestingly, the three somatic blastomeres poor in H3K4me3 are descendants of the first germline blastomere, implying an activity that impedes on H3K4me3 deposition in these cells. In contrast, the deposition of H3K4me2 and H3K27me2/3 is not lineage restricted. Taken together, our data reveal that H3K4me3 deposition is highly regulated according to the cell lineage involved.
Introduction
One of the most fascinating processes of early embryogenesis is the production of cells with two fundamentally different programs: the somatic program, which produces cells that are destined to die, and the germline program responsible for immortality of the species. Hence, the germline blastomeres face a dilemma at each cell division: to retain totipotency or to engage the somatic program.
Transcription is highly regulated during early embryogenesis and is important to establish the distinction between somatic and germline fates (Mello et al., 1992 (Mello et al., , 1996 Seydoux and Strome, 1999) . Transcription transits rapidly from a generally inactive state in all lineages to an active state specifically in the somatic lineage (Edgar et al., 1994; Seydoux and Dunn, 1997; Seydoux and Fire, 1994) . In contrast, the germline lineage remains poor in transcriptional activity.
An important determinant of somatic versus germline lineage is PIE-1 (Mello et al., 1992) . PIE-1 has been shown to segregate in the P lineage and to disappear when P4 undergoes the final symmetric division (Mello et al., 1996) . PIE-1 is an RNA binding protein that can repress transcription in human cell culture (Zhang et al., 2003) . Deletion of pie-1 causes a dramatic effect on the embryonic lineage; the P2 lineage loses its germline program and acquires a somatic program, causing the production of extra intestinal cells (Mello et al., 1996; Seydoux and Strome, 1999) . Therefore, PIE-1 is essential to suppress the somatic program, possibly by general repression of transcription.
There is strong evidence that chromatin organisation is important for germline development. Work on MES-2, MES-3, and MES-6, the Polycomb Group-like complex in Caenorhabditis elegans, has shown that these prevent degeneration of the germline and sterility through deposition of H3K27me2/3 marks (Bender et al., 2004; Capowski et al., 1991; Shin and Mello, 2003) . It was also shown that defects in erasure of the H3K4me2 marks in the Z2 and Z3 cells compromises germline immortality (Katz et al., 2009; Schaner et al., 2003; Schaner and Kelly, 2006) . Furthermore, inactivation of members of the NuRD (nucleosome remodelling deacetylase) complex, a chromatin remodelling complex involved in repression of transcription, causes the ectopic expression of germline markers in the soma (Unhavaithaya et al., 2002) . Therefore, chromatin organisation is critical to retain the germline program and also to prevent its expression in the somatic lineage.
Di-or trimethylation marks on H3K4 and H3K27 correlate with activation of transcription and with repression of transcription, respectively. Consequently, H3K4me2/3 and H3K27me2/3 are mainly found at different loci (Cao et al., 2002; Ringrose and Paro, 2004; Ruthenburg et al., 2007) . Despite this anti-correlation, a limited number of loci have been found co-occupied by H3K4/K27me3 marks. These loci tend to be transcriptionally inactive and to encode for developmentally regulated transcription factors ready to be activated at the appropriate time (Azuara et al., 2006; Bernstein et al., 2006) .
Methylation marks are deposited and removed by enzymes. A number of these enzymes are part of the MLL3/SET1 complex in humans, and we will refer herein to its C. elegans counterpart as the MLL complex. The MLL complex has a methyltransferase activity targeting H3K4 and a demethylase activity targeting H3K27 Fisher et al., 2010; Issaeva et al., 2007; Lan et al., 2007; Lee et al., 2007) . The complex can therefore deposit methyl marks on H3K4 (activation of transcription) and remove methyl marks from H3K27 (relieving repression of transcription) (Kouzarides, 2007) . The MLL complex requires core components to be effective: WDR-5, ASH-2, and RBBP-5 (Ruthenburg et al., 2007) . The MLL complex can also contain at least two methyltransferases (SET-16 or SET-2) (Fisher et al., 2010; Simonet et al., 2007) . All these components are conserved in humans.
Here, we investigated the levels of di-and trimethylation at both H3K4 and H3K27 sites during early embryogenesis. Since these marks correlate with either activation or repression of transcription, we anticipated that the germline blastomeres would be poor in H3K4me2/3 and rich in H3K27me2/3 relatively to the somatic blastomeres. Interestingly, only the H3K4me3 mark shows levels of deposition that differ between the different lineages. Indeed, the germline blastomeres and importantly some of the somatic blastomeres remain poor in H3K4me3. We also show using mutants that the MLL complex is active at an early stage in both the somatic and germline blastomeres. Interestingly, both PIE-1 and RBR-2 (a demethylase targeting H3K4) can affect H3K4me3 levels during early embryogenesis, but only PIE-1 can prevent H3K4me3 deposition in the germline blastomeres. Taken together, our data show that the deposition of the H3K4me3 mark is unique and dynamic compared to other epigenetic marks investigated here or reported by others.
Results

H3K4me3 in the early embryo and on chromosome X
The C. elegans early embryo is a good model to study how the somatic lineage differs from the germline lineage, because these lineages can be tracked in vivo. During early embryogenesis, the lineage that will generate the gametes is called the P lineage (P0, P1, P2, P3, and P4). P1-P4 originate from four successive asymmetric cell divisions that also give rise to four somatic blastomeres (or founder cells) (Sulston et al., 1983 ). P4 will later divide symmetrically to produce the primordial germ cells (PGCs), Z2 and Z3 ( Fig. 1A and B) . At this stage, the germline programme is distinct from the somatic programme (Schaner and Kelly, 2006; Seydoux and Strome, 1999) .
It was previously shown that transcription in two-and four-cell stage embryos is poor (Edgar et al., 1994; Seydoux and Fire, 1994) . Therefore, we investigated whether H3K27me2/me3, the repressionassociated marks, and H3K4me2/me3, the activation-associated marks, are detectable by immunofluorescence at these stages. We found that H3K4me2/me3, and H3K27me2/me3 are detectable marks and appear evenly distributed between the different cells of the embryos at both two-and four-cell stages (Fig. 1C , data not shown, and (Schaner et al., 2003) ). Therefore, the methylation marks analysed herein are all present during early embryogenesis, and each mark is distributed at comparable levels between cells.
The H3K4me2, H3K27me2, and H3K27me3 marks have been studied during post-embryonic germline development. During germline development the X chromosome is transcriptionally inactive (Reinke et al., 2000) . Accordingly, the X chromosome is devoid of the H3K4me2 mark (Kelly et al., 2002; Reuben and Lin, 2002) , and enriched for both the H3K27me2/me3 marks (Bender et al., 2004) . We predicted that H3K4me3 should adopt a similar localisation as H3K4me2, and indeed we found a chromosomal area devoid of H3K4me3 (Fig. 1D ). This pattern of deposition suggests that the antibody against H3K4me3 recognised the correct epitope. Nevertheless, we additionally performed a peptide competition assay, and show that a peptide trimethylated at K4 can abrogate the H3K4me3 signal, but a peptide trimethylated at K27 has no effect (Fig. 1E) . Taken together, the pattern of deposition, the competition assays, and other data provided below indicate that this antibody is specific to the H3K4me3 mark.
Cell lineage specific deposition of H3K4me3 at the eight-cell stage Transcription has been shown to be active at the eight-cell stage (Edgar et al., 1994) . Interestingly, it is at this stage that we observed a striking difference in H3K4me3 deposition. In contrast, the other methylation marks (H3K4me2, H3K27me2, and H3K27me3) remained unchanged. The cells poor in H3K4me3 are the germline blastomere (P3) and three somatic blastomeres: MS, E, and C ( Fig. 2A) . The four somatic blastomeres enriched for H3K4me3 are all AB descendants ( Fig. 2A) . We ensured that these four cells are descendants of the AB lineage by performing co-immunofluorescence with an antibody against GLP-1. GLP-1 is a Notch homolog found at the membrane and within the cytoplasm. Importantly, it is expressed only in the AB lineage at the early stages of embryogenesis (Evans et al., 1994) . At four-cell stage only ABa and ABp express GLP-1, confirming that GLP-1 is specific to the AB lineage ( Fig. 2B ). We next analysed the eight-cell stage and found that only four cells are positive for GLP-1 expression, and that these cells show high levels of H3K4me3 deposition (Fig. 2C ). This indicates that H3K4me3 deposition is high in the AB lineage. We also performed a co-staining using an antibody against PGL-1, which confirms that levels of H3K4me3 are low in the P3 cell ( Supplementary Fig. 1 ). We next quantified the abundance of H3K4me3 relative to H3K27me2 using confocal microscopy (Fig. 2D ). We analysed 80 cells from ten embryos, and found a 3.3 fold enrichment in H3K4me3 deposition in the AB descendants compared with the P1 descendants (Fig. 2E ). We have also produced 3D movies to help visualise these data ( Supplementary Fig. 2 ). Accordingly, similar results were obtained from another commercially available antibody against H3K4me3 ( Supplementary Fig. 3 ). Taken together, these data lead us to conclude that the H3K4me3 mark is regulated according to the cell lineage. Indeed, the somatic blastomeres derived from P1, as well as P3, are resistant to accumulation of H3K4me3.
Since at eight-cell stage we have observed four H3K4me3-depeleted cells, we expected that following an additional cell division, eight cells (seven somatic cells and P4) would remain depleted of H3K4me3, but this is not the case. Indeed, only three somatic cells and P4 remain poor in H3K4me3. This implies that half of the descendants of the four H3K4me3-depeleted cells are capable of acquiring the H3K4me3 mark (Fig. 3A) . Accordingly, high levels of H3K4me3 are detected in all somatic cells at the post-gastrulation stage (Fig. 3B) . As expected, Z2 and Z3, the PGCs, are depleted of the H3K4me3 mark (Fig. 3B ) and of the H3K4me2 mark (Katz et al., 2009; Schaner et al., 2003) . Therefore, the deposition of the H3K4me3 mark is a very dynamic process.
The MLL complex is responsible for acquisition of H3K4me3 during early embryogenesis
We next addressed whether the deposition of H3K4me3 during early embryogenesis requires the MLL complex. We used mutants of Fig. 1 . The H3K4me3 mark during early embryonic development. (A) Depiction of the early embryo lineage. The one cell embryo first divides asymmetrically to generate the AB and P lineages. The AB lineage is entirely formed of somatic cells. The P lineage produces the germline blastomeres (P1, P2, P3, and P4 (green and blue)), the somatic blastomeres (EMS, C and D (green)), and the primordial germ cells (Z2 and Z3 (blue)). The latter will generate all the gamete of the adult hermaphrodite. (B) Depiction of the two-, four-, and eight-cell stages of the embryo. In green are the somatic blastomeres, and in green and blue are the germline blastomeres. (C) The H3K4me3 and H3K27me2 marks are detected in all the cells of the embryos at two-and four-cell stages. Co-immunostaining for H3K4me3, H3K27me3 and DNA by DAPI are shown as well as the corresponding DIC picture. (D) A chromosomic area at pachytene stage is depleted of the H3K4me3 mark. E) Competition assays using peptides as indicated followed by immunostaining provide further evidence that the H3K4me3 antibody is specific. Two-cell stage embryos are presented, but similar data were also obtained at later stages of development and also in the germlines. the core components (wdr-5 and rbbp-5) as well as a set-2 mutant. SET-2 is one of the two methyltransferases targeting H3K4 that have been shown to be part of the complex (Fisher et al., 2010; Simonet et al., 2007) . Initially, we performed co-immunofluorescence at two-, and four-cell stages in the wdr-5 mutant. This mutant has already been shown to be impaired in deposition of H3K4me3 (Fisher et al., 2010; Simonet et al., 2007) , but not at early stages of embryonic development. We started our analysis at the two-cell stage, and could still detect H3K4me3 deposition, though the signal appeared weaker than in wild type worms (Fig. 4A) . However, at four-cell stage, we were unable to detect the H3K4me3 mark (Fig. 4B) . Noteworthy, we found no defect in levels of deposition of H3K27me2 (Figs. 4A and B) or of H3K27me3 (data not shown).
Additionally, we analysed the eight-cell stage and found that the H3K4me3 mark is undetectable in wdr-5, rbbp-5, and set-2 mutants compared to N2 (Fig. 5A) . We performed the same systematic analysis at post-gastrulation stage. We obtained the same result with wdr-5 and rbbp-5 mutants, but surprisingly the set-2 mutant showed a detectable albeit low level of H3K4me3 (Fig. 5B) . To ensure that these observations based on immunofluorescence are not due to masking of specific epitopes, we performed western blot analysis using extracts from wdr-5, rbbp-5, and ash-2 mutants and compared levels of H3K4me3 to wild type embryo extracts. We found that in all the mutant cases, H3K4me3 is undetectable, which is consistent with our immunofluorescence data (Fig. 5C) . We conclude that the MLL complex is required for appropriate deposition of H3K4me3 during embryogenesis.
H3K4me3 deposition remains low in germline blastomeres from rbr-2 mutants
Our observations are consistent with a dynamic and lineage specific regulation of H3K4me3 deposition during embryogenesis, in which the MLL complex must be playing an important role in cells rich in H3K4me3. However, poor deposition of H3K4me3 could be can act on H3K4me3/me2, which makes RBR-2 a good candidate, since it can target H3K4me3 . To test whether demethylation by RBR-2 contributes to the H3K4me3 pattern of deposition, we used an rbr-2 mutant, and analysed its effect at multiple stages, including the eight-cell stage. At this stage, we found that the rbr-2 embryos deposit H3K4me3 in a pattern similar to wild type animals (Fig. 6A , eight-cell stage). Importantly, we could not detect H3K4me3 deposition in the P4 or later in Z2 and Z3, the PGCs (Fig. 6A, P4 and Z2-Z3). However, when we compared the H3K4me3 levels between the rbr-2 mutant and wild type, we observed an enrichment of H3K4me3 in the somatic cells (Fig. 6B) . We quantified this observation using western blot analysis, and detected about four times the level of H3K4me3 in rbr-2 embryos compared with wild type, with no effect on H3K27me3 deposition (Fig. 6C) . Therefore, RBR-2 is not involved in preventing H3K4me3 deposition in the P lineage, but could play a role in regulating somatic deposition of H3K4me3.
Absence of PIE-1 activates deposition of H3K4me3 in the P lineage PIE-1 has been shown to be critical to maintain the germline fate through repression of transcription in the P lineage (Mello et al., 1992; Mello et al., 1996; Seydoux and Strome, 1999; Zhang et al., 2003) . Herein, we have shown that deposition of H3K4me3, an activation mark, is low in the P lineage. Hence, we tested whether the absence of PIE-1, a repressor of transcription, could promote the deposition of H3K4me3 in the P lineage, and the somatic descendants of P1. Using a pie-1 mutant and performing similar analysis as presented above, we did not observe an effect on the deposition of H3K4me3 at two-and four-cell stages (Figs. 7AB) . However, we found that at eight-cell stage, the embryos depleted of PIE-1 acquire the H3K4me3 mark in P3 and in the somatic cells in which H3K4me3 is normally poor (Fig. 7C) . Strikingly, even at later stages of development, we observed deposition of H3K4me3 in P4 (Fig. 7D ). Therefore PIE-1 is critical to prevent accumulation of H3K4me3 in germline blastomeres and in the somatic descendants of P1.
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H3K4me3 deposition is robust in the germline
The effect that the wdr-5 mutant has on levels of H3K4me3 in embryo is striking (Fig. 5 ). But surprisingly, previous studies have shown that L4 or adults express levels of H3K4me3 that can easily be detected by Westerns blot analysis (Fisher et al., 2010; Simonet et al., 2007) . One explanation (other than the sensitivity of the methods) for these results is that the germ cells of the wdr-5 animals maintain robust deposition of H3K4me3. Hence, we tested this possibility by performing immunostaining in the gonads of wdr-5 mutants. We found that in the wild type gonads, the H3K4me3 pattern of deposition is dynamic. It is at a lower level in the mitotic zone, but at a higher level in the other zones (Fig. 8A) . In contrast, the differential distribution of the H3K27me2 modification is similar between the different zones, in particular if the DAPI signal is taken into consideration (Fig. 8A) . Importantly, in the wdr-5 gonads, the H3K4me3 mark is detectable, but its deposition pattern has changed (Fig. 8B ). It appears that the zone normally low in H3K4me3 levels is extended in wdr-5 mutants (Fig. 8B) . This may explain the source of H3K4me3 detected by western blot analysis in wdr-5 animals (Fisher et al., 2010; Simonet et al., 2007) , and also suggests that H3K4me3 deposition in the germline is more robust than in the embryo. Importantly, our data from embryos and the germline imply that embryonic viability and fertility could be affected in mutants of the core MLL complex. Hence, we assessed these functions in the wdr-5, rbbp-5 and ash-2 mutants. We found that embryonic viability and fertility in all mutants are compromised at both 20°C and 25°C. But surprisingly, these functions are affected differentially. For example, the wdr-5 mutant produces 45% embryonic lethality at 25°C compared with 16% for rbbp-5 (p b 0.005) and 0% for ash-2 (p b 0.00005) ( Table 1) . On the other hand, brood size is more affected in ash-2 (6 progeny, p b 0.0005) or rbbp-5 (19 progeny, p b 0.001) than in wdr-5 (54 progeny) ( Table 1) . Perhaps this is an indication that the MLL core complex can associate with different partners according to the site of expression. Despite this extra layer of complexity, our data support the view that proper embryonic development and fertility requires deposition of methyl groups on H3K4.
Discussion
Transcriptional activity during early embryogenesis is poor in the germline blastomeres, but processive in the somatic blastomeres (Edgar et al., 1994; Schaner and Kelly, 2006; Schaner et al., 2003; Seydoux and Dunn, 1997; Seydoux and Fire, 1994; A B Strome, 1999). Previous studies have investigated the deposition of methylation and acetylation marks during early embryogenesis and found that H3K4me2 is actively removed from the PGCs later during embryogenesis (N26-cell stage). Prior to this stage, the levels of H3K4me2 (and other marks) remain equivalent in all cells of the early embryo (Katz et al., 2009; Schaner and Kelly, 2006; Schaner et al., 2003) . Similarly, we found that H3K4me2 and H3K27me2/me3 levels remain equivalent prior to the generation of PGCs. However, we uncovered that the H3K4me3 mark has a unique distribution during embryogenesis. Indeed, some of the somatic blastomeres and the germline blastomeres fail to accumulate the H3K4me3 marks. Interestingly, this characteristic is regulated by PIE-1. Therefore, it is likely that deposition of the H3K4me3 mark is important for the development of the germline blastomeres. Prior to this study there was no evidence that the chromatin architecture of germline blastomeres could be different from somatic blastomeres. Indeed, most data indicated that, at least at a superficial level, both types of blastomeres were equivalent in deposition of numerous metylation and acetylation marks thereby implying that their chromatin architecture was similar. Here, we provide new insights into a possible role that a specific mark (H3K4me3) may play to ensure that the chromatin architecture adopted in the germline blastomeres is in accordance with its transcriptional status. Consistent with this role, we found that in absence of PIE-1, deposition of H3K4me3 is restored in germline blastomeres, and that the differential deposition between somatic blastomeres at the eightcell stage is abolished. Therefore, these data imply interplay between the general transcriptional repressor PIE-1 and the chromatin architecture of the germline blastomeres.
The observation that specific somatic blastomeres fail to accumulate the H3K4me3 mark was unexpected. Interestingly, the somatic blastomeres "resistant" to the deposition of the third methylation mark on H3K4 are derived from the germline blastomere P1. Hence, we would like to raise the possibility that the P1 germline blastomere produces an activity that prevents the MLL complex to deposit the third methylation mark on H3K4 or/and that it stimulates its removal by a still undiscovered demethylase. However, this putative activity from P1 may not affect directly the MLL complex or the demethylase, but could affect the deposition or removal of other marks on the chromatin leading to the effect characterised herein. Our data appear to rule out RBR-2 as a potential demethylase, since it is not required to maintain the H3K4me3 deposition pattern at the eight-cell stage (Fig. 6) . Finally, considering that the germline blastomere is a type of stem cell, our findings may provide new insights into how totipotency (and perhaps also pluripotency) can be maintained by controlling the deposition of the third methyl mark on H3K4.
Materials and methods
Strains and general maintenance
Strains were maintained as previously described (Brenner, 1974) . The strains used in this study were: wdr-5(ok1417), set-2 (ok952), rbbp-5(tm3463), ash-2(tm1905), rbr-2(tm1231), pie-1(zu154) unc-25 (e156)/qC1 dpy-19(e1259) glp-1(q339) and Bristol N2 as wild type.
Co-immunofluorescence
Immunofluorescence by freeze crack was performed on polylysine treated slides at 0.3%. Slides treated by application of 75 μl of polylysine 0.3%, dried 10 min at 70°C, quickly rinsed in distilled water and excess liquid wiped off. The slides were 3 × 14 mm printed wells from Fisher Scientific LTD UK. About 30 mothers were placed in a well with a drop of M9 buffer, to wash off bacteria. These mothers were transferred into a 5-6 μl drop of M9 onto the polylysine treated well using an eyelash. A cover slip (22 mm × 50 mm) was applied at a right angle and the slide placed at −80°C for at least 20 min. The cover slip was then promptly removed and embryos methanol fixed at −20°C for 10 min, washed 5 min in PBS, and then followed by two washes in PBS-tween 0.2%. Primary antibody was incubated overnight at 4°C in a humid chamber. Washes performed as described above. Secondary antibody was incubated 2 h at 37°C. Washes performed as described above. Mowiol was applied to preserve fluorescence. Primary antibodies used: anti-H3K4me3 (Abcam, ab1012 and ab8580), anti-H3K4me2 (Abcam, ab32356), anti-H3K27me3 (Millipore/Upstate, 07-449), anti-H3K27me2 (Millipore/Upstate, 07-452), and anti-H3 (Abcam, 1791). The secondary antibodies used are from Jackson ImmunoResearch: DyLight 594 AffiniPure Goat Anti-Mouse IgG (H + L) (cat.115-515-146) and DyLight 488 AffiniPure Goat AntiRabbit IgG (H + L) (cat.111-485-144). Our controls performed without primary antibody show that these secondary antibodies do not produce significant background (data not shown).
Image processing
Confocal images were analysed using imageJ software. Individual slices were selected for every cell to discriminate between overlapping cells. We used eight-cell stage embryos in which AB descendants are distinctive from P1 descendants, i.e. the AB cells enter mitosis faster than the P1 linage. We expressed the results as a ratio of the H3K4me3 signal over the H3K27me2 signal for each cells.
Peptide competition assays
Peptides were preincubated in three fold excess with the antiH3K4me3 (ab1012) at room temperature for 30 min prior to immunostainings. Immunostainings were performed as described above. The peptides used were produced by Abcam (ab1432, H3K4me3) and (ab1782, H3K27me3).
Western blot analysis
Western blot analysis was performed as described in (Fisher et al., 2010 ) with a few modifications. Briefly, embryo protein extracts were prepared by bleaching young mothers followed by washing the embryos four times with M9 buffer. A minimum volume of 20 μl pelleted embryos was collected for each protein sample, boiled in Laemmli buffer containing 100 mM DTT and sonicated.
Embryonic and fertility analysis
To calculate brood size and embryonic lethality ten clones per strain were transferred onto fresh plates every day until the worms had finished laying. The number of embryos and progeny were counted each day. Embryos are considered dead if they did not hatch after more than 24 h and appeared grossly abnormal.
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